cysteine and cytidine diphosphate

cysteine has been researched along with cytidine diphosphate in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's1 (25.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bollinger, JM; Johnston, MI; Mao, SS; Stubbe, J1
Persson, AL; Sahlin, M; Sjöberg, BM1
Lohman, GJ; Stubbe, J; Wang, J1
Hansen, R; Li, LS; Lito, P; Rosen, N; Solomon, M1

Other Studies

4 other study(ies) available for cysteine and cytidine diphosphate

ArticleYear
Mechanism-based inhibition of a mutant Escherichia coli ribonucleotide reductase (cysteine-225----serine) by its substrate CDP.
    Proceedings of the National Academy of Sciences of the United States of America, 1989, Volume: 86, Issue:5

    Topics: Cloning, Molecular; Cysteine; Cytidine Diphosphate; Cytosine Nucleotides; Escherichia coli; Kinetics; Mutation; Ribonucleotide Reductases; Serine

1989
Cysteinyl and substrate radical formation in active site mutant E441Q of Escherichia coli class I ribonucleotide reductase.
    The Journal of biological chemistry, 1998, Nov-20, Volume: 273, Issue:47

    Topics: Catalytic Domain; Cysteine; Cytidine Diphosphate; Electron Spin Resonance Spectroscopy; Escherichia coli; Free Radicals; Models, Chemical; Mutation; Ribonucleotide Reductases; Spin Trapping

1998
Enhanced subunit interactions with gemcitabine-5'-diphosphate inhibit ribonucleotide reductases.
    Proceedings of the National Academy of Sciences of the United States of America, 2007, Sep-04, Volume: 104, Issue:36

    Topics: Cysteine; Cytidine Diphosphate; Deoxycytidine; Enzyme Activation; Escherichia coli; Gemcitabine; Humans; Molecular Structure; Molecular Weight; Protein Binding; Protein Subunits; Ribonucleotide Reductases; Time Factors

2007
Allele-specific inhibitors inactivate mutant KRAS G12C by a trapping mechanism.
    Science (New York, N.Y.), 2016, Feb-05, Volume: 351, Issue:6273

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Alleles; Antineoplastic Agents; Azetidines; Cell Line, Tumor; Cysteine; Cytidine Diphosphate; Enzyme Inhibitors; Glycine; Guanosine Triphosphate; HEK293 Cells; Humans; Lung Neoplasms; Molecular Targeted Therapy; Mutation; Piperazines; Protein Conformation; Proto-Oncogene Proteins p21(ras); Time Factors

2016